Genetic factors in the aetiology of non-insulin-dependent diabetes

Frontiers of Hormone Research

Volumn 22, Issue , 1997, Pages 157-178

  Hattersley, Andrew ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009708655     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (100)

1. Leopold EJ: Aretaeus the Cappadocian; in von Engelhardt D (ed): Diabetes. Its Medical and Cultural History. Berlin, Springer, 1989, pp 125-140.
2. O'Rahilly S, Wainscoat JS, Turner RC: Type 2 (non-insulin-dependent) diabetes: New genetics for old nightmaetes. Diabetologia 1988;31:407-414.
3. Schadewaldt H: The history of diabetes mellitus; in von Engelhardt D (ed): Diabetes: Its Medical and Cultural History. Berlin, Springer, 1989, p 43.
4. Simpson NE: The genetics of diabetes mellitus: A review of family data; in Creutzfeldt W, Kobberling J, Neel J (eds): The Genetics of Diabetes mellitus. Berlin, Springer, 1976, pp 12-20.
5. Harris H: The familial distribution of diabetes mellitus: A study of the relatives of 1241 diabetic propositi. Ann Eug 1950;15:95-116.
6. Hitman GA, McCarthy MI: Genetics of non-insulin-dependent diabetes mellitus (review). Baillieres Clin Endocrinol Metab 1991;5:455-476.
7. Turner RC, Hattersley AT, Shaw JT, Levy JC: Type II diabetes: Clinical aspects of molecular biological studies (review). Diabetes 1995;44:1-10.
8. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987;30:123-131.
9. Rimoin D, Rotter J: Genetic syndromes associated with diabetes mellitus and glucose intolerance; in The Genetics of Diabetes mellitus. London, Academic Press, 1982, pp 149-182.
10. Cook JT, Hattersley AT, Levy JC, et al: Distribution of type II diabetes in nuclear families. Diabetes 1993;42:106-112.
11. Home P: The OGTT: Gold that does not shine. Diabet Med 1988;5:313-314.
12. Tattersall RB: Mild familial diabetes with dominant inheritance. Q J Med 1974;43:339-357.
13. Tattersall RB, Mansell PI: Maturity onset-type diabetes of the young (MODY): One condition or many? (review). Diabet Med 1991;8:402-410.
14. Fajans SS: Scope and heterogeneous nature of MODY (review). Diabetes Care 1990;13:49-64.
15. Cox NJ, Xiang KS, Fajans SS, Bell GI: Mapping diabetes-susceptibility genes: Lessons learned from search for DNA marker for maturity-onset diabetes of the young (review). Diabetes 1992;41:401-407.
16. Ott J: Analysis of Human Genetic Linkage. Baltimore, Johns Hopkins University Press, 1985.
17. Lander E, Botstein D: Mapping complex genetic traits in humans: New methods using a complete RFLP linkage map. Cold Spring Harb Symp Quant Biol 1986;LI:49-62.
18. Hattersley AT, Turner RC: Mutations of the glucokinase gene and type 2 diabetes (review). Q J Med 1993;86:227-232.
19. Taylor SI: Lilly lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene (review). Diabetes 1992;41:1473-1490.
20. Bell GI, Xiang KS, Newman MV, et al: Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Nat Acad Sci USA 1991;88:1484-1488.
21. Byrne MM, Sturis J, Fajans SS, et al: Altered insulin secretory responses to glucose in subjects with a mutation in the MOBY1 gene on chromosome 20. Diabetes 1995;44:699-704.
22. Matschinsky F, Liang Y, Kesavan P, et al: Glucokinase as pancreatic beta cell glucose sensor and diabetes gene (review). J Clin Invest 1993;92:2092-2098.
23. Tanizawa Y, Matsutani A, Chiu KC, Permutt MA: Human glucokinase gene: Isolation, structural characterization, and identification of a microsatellite repeat polymorphism. Mol Endocrinol 1992;6:1070-1081.
24. Tanizawa Y, Chiu KC, Province MA, et al.: Two microsatellite repeat polymorphisms flanking opposite ends of the human glucokinase gene: Use in haplotype analysis of Welsh Caucasians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36:409-413.
25. Froguel P, Vaxillaire M, Sun F, et al: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992;356:162-164.
26. Hattersley AT, Turner RC, Permutt MA, et al: Linkage of type 2 diabetes to the glucokinase gene. Lancet 1992;339:1307-1310.
27. Gidh-Jain M, Takeda J, Xu LZ, et al: Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: Implications for structure/function relationships. Proc Nat Acad Sci USA 1993;90:1932-1936.
28. Katagiri H, Asano T, Ishihara H, et al: Nonsense mutation of glucokinase gene in late-onset non-insulin-dependent diabetes mellitus. Lancet 1992;340:1316-1317.
29. Stoffel M, Patel P, Lo YM, et al: Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nature Genet 1992;2:153-156.
30. Zouali H, Vaxillaire M, Lesage S, et al: Linkage analysis and molecular scanning of glucokinase gene in NIDDM families. Diabetes 1993;42:1238-1245.
31. Stoffel M, Bell K, Blackburn C, et al: Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Diabetes 1993;42:937-940.
32. Hattersley AT, Saker PJ, Barrow B, et al: A missense mutation in the glucokinase gene in gestational diabetic subjects (abstract). Diabet Med 1993;10:S4.
33. Froguel P, Zouali H, Vionnet N, et al: Familial hyperglycemia due to mutations in glucokinase: Definition of a subtype of diabetes mellitus. N Eng J Med 1993;328:697-702.
34. Page RC, Hattersley AT, Levy JC, et al: Clinical characteristics of subjects with a missense mutation in glucokinase. Diabet Med 1995;12:209-217.
35. Velho G, Froguel P, Clement K, et al: Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 1992;340:444-448.
36. Byrne MM, Sturis J, Clement K, et al: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994;93:1120-1130.
37. Vaxillaire M, Boccio V, Philippi A, et al: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genet 1995;9:418423.
38. Menzel S, Yamagata K, Trabb J, et al: Localization of MODY3 to a 5-cM region of human chromosome 12. Diabetes 1995;44:1408-1413.
39. Holt IJ, Harding AE, Morgan-Hughes JA: Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-719.
40. Holt IJ, Harding AE, Cooper JM, et al: Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989;29:699-708.
41. Ballinger SW, Shoffner JM, Hedaya EV, et al: Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet 1992;1:11-15.
42. Ballinger SW, Shoffner JM, Gebhart S, Koontz DA, Wallace DC: Mitochondrial diabetes revisited (letter). Nature Genet 1994;7:458-459.
43. van den Ouweland JM, Lemkes HH, Ruitenbeek W, et al: Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet 1992;1:368-371.
44. Schon EA, Koga Y, Davidson M, Moraes CT, King MP: The mitochondrial tRNA(Leu)(UUR) mutation in MELAS: A model for pathogenesis. Biochim Biophy Acta 1992;1101:206-209.
45. Vionnet N, Passa P, Froguel P: Prevalence of mitochondrial gene mutations in families with diabetes mellitus (letter). Lancet 1993;342:1429-1430.
46. Reardon W, Ross RJ, Sweeney MG, et al: Diabetes mellitus asociated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992;340:1376-1379.
47. Oka Y, Katagiri H, Yazaki Y, Murase T, Kobayashi T: Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 1993;342:527-528.
48. Sue CM, Holmes-Walker DJ, Morris JG, Boyages SC, Crimmins DS, Byrne E: Mitochondrial gene mutations and diabetes mellitus (letter). Lancet 1993;341:437-438.
49. Awata T, Matsumoto T, Iwamoto Y, Matsuda A, Kuzuya T, Saito T: Japanese case of diabetes mellitus and deafness with mutation in mitochondrial tRNA(Leu(UUR)) gene (letter). Lancet 1993;341:1291-1292.
50. Kadowaki H, Tobe K, Mori Y, et al: Mitochondrial gene mutation and insulin-deficient type of diabetes mellitus (letter). Lancet 1993;341:893-894.
51. Aloalado JC, Majid A, Brockington M, et al: Mitochondrial gene defects in patients with NIDDM. Diabetologia 1994;37:372-376.
52. Alcolado JC, Thomas AW: Maternally inherited diabetes mellitus: The role of mitochondrial DNA defects (review). Diabet Med 1995;12:102-108.
53. Kadowaki T, Kadowaki H, Mori Y, et al: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Eng J Med 1994;330:962-968.
54. Kishimoto M, Hashiramoto M, Araki S, et al: Diabetes mellitus carrying a mutation in the mitochondrial tRNA(leu(UUR)) gene. Diabetologia 1995;38:193-200.
55. Taylor SI, Cama A, Accili D, et al: Mutations in the insulin receptor gene (review). Endocr Rev 1992;13:566-595.
56. O'Rahilly S, Choi WH, Patel P, Turner RC, Flie JS, Moller DE: Detection of mutations in insulin receptor gene in NIDDM patients by analysis of single-stranded polymorphisms. Diabetes 1991;40:777-782.
57. Hua QX, Shoelson SE, Inouye K, Weiss MA: Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus. Proc Nat Acad Sci USA 1993;90:582-586.
58. Cock JT, Page RC, O'Rahilly S, et al: Availability of type II diabetic families for detection of diabetes susceptibility genes. Diabetes 1993;42:1536-1543.
59. Risch N: Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 1990;46:229-241.
60. Risch N: Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990;46:222-228.
61. Risch N: Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 1990;46:242-253.
62. Bishop DT: The power of identify-by-state methods for linkage analysis. Am J Hum Gent 1990;46:254-265.
63. Murray JC, Buetow KH, Weber JL, et al: A comprehensive human linkage map with centimorgan density: Cooperative Human Linkage Center (CHLC). Science 1994;265:2049-2054.
64. Kobberling J, Tillil H: Empirical risk figures for first degree relatives of non-insulin-dependent diabetics, in Kobberling J, Tattersall R (ed): The Genetics of Diabetes mellitus. London, Academic Press, 1982, pp 201-210.
65. Cook JT, Shields DC, Page RC, et al: Segregation analysis of NIDDM in Caucasian families. Diabetologia 1994;37:1231-1240.
66. Cox NJ, Bell G: Disease associations: Chance, artefact or susceptibility genes. Diabetes 1989;38:947-950.
67. Lander ES, Schork NJ: Genetic dissection of complex traits (review). Science 1994;265:2037-2048.
68. Serjeantson SW, Owerbach D, Zimmet P, Nerup J, Thoma K: The genetics of diabetes in Nauru: Effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism. Diabetalogia 1983;25:13-17.
69. Scott J: Apolipoprotein E and Alzheimer's disease (review). Lancet 1993;342:696.
70. Julier C, Hyer RN, Davies J, et al: Insulin-IGF2 region on chromosome lip encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 1991;354:155-159.
71. Bain SC, Prins JB, Hearne CM, et al: Insulin gene region-encoded susceptibility to type 1 diabetes is not restricted to HLA-DR4-positive individuals. Nature Genet 1992;2:212-215.
72. Olansky L, Janssen R, Welling C, Permutt MA: Variability of the insulin gene in American blacks with NIDDM: Analysis by single-strand conformational polymorphisms. Diabetes 1992;41:742-749.
73. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O: Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993;342:828-832.
74. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS: Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 1994;94:1141-1146.
75. Hitman GA, Hawrami K, McCarthy MI, et al: Insulin receptor substrate-1 gene mutations in NIDDM: Implications for the study of polygenic disease. Diabetologia 1995;38:481-486.
76. Hager J, Zouali H, Velho G, Froguel P: Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families (letter). Lancet 1993;342:1430.
77. Zimmet PZ, Tuomi T, Mackay IR, et al: Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994;11:299-303.
78. Groop LC, Eriksson J, Ekstrand A, Franssila-Kallunki A, Saloranta C, Miettinen A: Metabolic characteristis of autoimmune diabetes mellitus in adults. Diabetologia 1991;34:46-51.
79. Groop L, Koskimies S, Pelkonen R, Tolppanen EM: Increased frequency of HLA-Cw4 in type 2 diabetes. Acta Endocrinologica 1983;104:475-478.
80. Prochazka M, Lillioja S, Tait JF, et al: Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 1993;42:514-519.
81. Humphreys P, McCarthy M, Tuomilehto J, et al: Chromosome 4q locus associated with insulin resistance in Pima Indians: Studies in three European NIDDM populations. Diabetes 1994;43:800-804.
82. Baier LJ, Sacchettini JC, Knowler WC, et al: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995;95:1281-1287.
83. Groop LC, Kankuri M, Schalin-Jantti C, et al: Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus (published erratum appears in N Engl J Med 1993;328:1136, see comments). N Engl J Med 1993;328:10-14.
84. Kadowaki T, Kadowaki H, Yazaki Y: Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus (letter, comment). N Engl J Med 1993;328:1568-1569.
85. Zouali H, Velho G, Froguel P: Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus (letter, comment). N Eng J Med 1993;328:1569.
86. Elbein SC, Hoffman M, Ridinger D, Otterud B, Leppert M: Description of a second microsatellite marker and linkage analysis of the muscle glycogen synthase locus in familial NIDDM. Diabetes 1994;43:1061-1065.
87. Kuroyama H, Sanke T, Ohagi S, et al: Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia 1994;37:536-539.
88. Shimokawa K, Kadowaki H, Sakura H, et al: Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects wih non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 1994;202:463-469.
89. Hamada Y, Ikegami H, Fujioka Y, et al: The glycogen synthase gene in NIDDM and hypertension. Diabetologia 1995;38:1249-1250.
90. Orho M, Nikula-Ijas P, Schalin-Jantti C, Permutt MA, Group LC: Isolated and characterization of the human muscle glycogen synthase gene. Diabetes 1995;44:1099-1105.
91. Hager J, Hansen L, Vaisse C, et al: A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nature Genet 1995;9:299-304.
92. Huang X, Orho M, Lehto M, Groop L: Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland. Diabetologia 1995;38:1246-1248.
93. Fujisawa T, Ikegami H, Yamato E, et al: A mutation in the glucagon receptor gene (Gly40Ser): Heterogeneity in the association with diabetes mellitus. Diabetologia 1995;38:983-985.
94. Clement K, Vaisse C, Manning BS, et al: Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity (see comments). N Eng J Med 1995;333:352-354.
95. Walston J, Silver K, Bogardus C, et al: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Eng J Med 1995;333:343-347.
96. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC: Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-351.
97. Hastbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A, Lander E: Linkage disequilibrium mapping in isolated founder populations: Diatrophic dysplasia in Finland. Nature Genet 1993;2:204-211.
98. Pritchard LE, Kawaguchi Y, Reed PW, et al: Analysis of the CD3 gene region and type 1 diabetes: Application of fluorescence-based technology to linkage disequilibrium mapping. Hum Molec Genet 1995;4:197-202.
99. Yamagata K, Oda N, Kaisaki PJ, et al: Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 1996;384:455-458.
100. Yamagata K, Furuta H, Oda N, et al: Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 1996;384:458-460.